glp-1 fda approval New Pill Foundayo (Orforglipron) Gets for Obesity FDA Approves Foundayo for Obesity
Description
By 2030, we expect the market size to exceed $100 billion in the U.S. It is estimated that by then, 1 in 10 Americans will be on a GLP-1 medication
Enhanced self-monitoring and accountability are fundamental, as frequent tracking of weight and behaviors is a consistent predictor of weight loss success [43]
doi: 10.1016/j.jhep.2020.03.039
Eat bland, easy-to-digest foods
Protein provides the necessary building blocks (amino acids) for muscle repair and maintenance
[DOI] [PMC free article] [PubMed] [Google Scholar] Wysham C., Blevins T., Arakaki R., Colon G., Garcia P., Atisso C., et al
